• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一系列1,8-萘啶拮抗剂对牛腺苷受体亲和力谱的定量构效关系研究。

Quantitative structure-activity relationship study on affinity profile of a series of 1,8-naphthyridine antagonists toward bovine adenosine receptors.

作者信息

Sharma B K, Sarbhai Kirti, Singh P, Sharma Susheela

机构信息

Department of Chemistry, S. K. Government College, Sikar, India.

出版信息

J Enzyme Inhib Med Chem. 2008 Jun;23(3):437-43. doi: 10.1080/14756360701655073.

DOI:10.1080/14756360701655073
PMID:18569352
Abstract

The affinity profiles for the bovine adenosine receptors, A(1) and A(2A), of a series of 1,8-naphthyridine derivatives were quantitatively analyzed using physicochemical and structural parameters of the substituents, present at varying positions of the molecules. The derived significant correlation, for bovine A(1) receptor, suggested that a R(1) substituent having a higher van der Waals volume, a R(2) substituent being a hydrogen-bond donor and a R(3) substituent able to transmit a higher field effect are helpful in augmenting the pK(i) of a compound. Similarly the study, pertaining to bovine A(2A) receptor, revealed that a less bulky substituent at R(2) and a strong electron-withdrawing substituent at R(3) are desirable in improving the binding affinity of a compound while substituents at R(1) remain insignificant to any interaction.

摘要

利用一系列1,8-萘啶衍生物分子不同位置上取代基的物理化学和结构参数,对牛腺苷受体A(1)和A(2A)的亲和力谱进行了定量分析。对于牛A(1)受体,得出的显著相关性表明,具有较高范德华体积的R(1)取代基、作为氢键供体的R(2)取代基以及能够传递较高场效应的R(3)取代基,有助于提高化合物的pK(i)。同样,关于牛A(2A)受体的研究表明,R(2)处体积较小的取代基和R(3)处强吸电子取代基有利于提高化合物的结合亲和力,而R(1)处的取代基对任何相互作用都无显著影响。

相似文献

1
Quantitative structure-activity relationship study on affinity profile of a series of 1,8-naphthyridine antagonists toward bovine adenosine receptors.一系列1,8-萘啶拮抗剂对牛腺苷受体亲和力谱的定量构效关系研究。
J Enzyme Inhib Med Chem. 2008 Jun;23(3):437-43. doi: 10.1080/14756360701655073.
2
Study on affinity profile toward native human and bovine adenosine receptors of a series of 1,8-naphthyridine derivatives.一系列1,8-萘啶衍生物对天然人源和牛源腺苷受体的亲和力研究。
J Med Chem. 2004 Jun 3;47(12):3019-31. doi: 10.1021/jm030977p.
3
A novel class of highly potent and selective A1 adenosine antagonists: structure-affinity profile of a series of 1,8-naphthyridine derivatives.
J Med Chem. 2000 Jul 27;43(15):2814-23. doi: 10.1021/jm990321p.
4
Quantitative structure-activity relationship study of new potent and selective antagonists at the 5-HT(1A) and adrenergic alpha(1d) receptors: Derivatives of spiroethyl phenyl(substituted)piperazine.
J Enzyme Inhib Med Chem. 2006 Oct;21(5):601-7. doi: 10.1080/14756360600810175.
5
Quantitative structure-activity relationship study of human A3 adenosine receptor antagonists: derivatives of 2-aryl-1,2,4-triazolo [4,3-alpha]quinoxaline.人A3腺苷受体拮抗剂的定量构效关系研究:2-芳基-1,2,4-三唑并[4,3-α]喹喔啉衍生物
J Enzyme Inhib Med Chem. 2007 Apr;22(2):165-9. doi: 10.1080/14756360601051290.
6
7-Amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives: structural investigations at the 5-position to target human A₁ and A(2A) adenosine receptors. Molecular modeling and pharmacological studies.7-氨基-2-苯基吡唑并[4,3-d]嘧啶衍生物:针对人 A₁ 和 A(2A) 腺苷受体在 5 位的结构研究。分子模拟和药理学研究。
Eur J Med Chem. 2014 Sep 12;84:614-27. doi: 10.1016/j.ejmech.2014.07.060. Epub 2014 Jul 19.
7
Targeting adenosine receptors with coumarins: synthesis and binding activities of amide and carbamate derivatives.香豆素类化合物靶向腺苷受体:酰胺和氨基甲酸酯衍生物的合成及结合活性。
J Pharm Pharmacol. 2013 Jan;65(1):30-4. doi: 10.1111/j.2042-7158.2012.01571.x.
8
A quantitative analysis of binding affinities of ligands active at adenosine receptors.
Drug Des Discov. 1994 Nov;12(2):169-77.
9
Quantitative structure-activity relationship study of benzylsulfanyl imidazoles as cytokine release inhibitors.
J Enzyme Inhib Med Chem. 2007 Feb;22(1):15-21. doi: 10.1080/14756360600952217.
10
1,2,4-Triazolo[1,5-a]quinoxaline derivatives: synthesis and biological evaluation as adenosine receptor antagonists.1,2,4-三唑并[1,5-a]喹喔啉衍生物:作为腺苷受体拮抗剂的合成及生物学评价
Farmaco. 2004 Feb;59(2):71-81. doi: 10.1016/j.farmac.2003.09.005.